{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T16:15:11Z","timestamp":1777652111653,"version":"3.51.4"},"reference-count":76,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T00:00:00Z","timestamp":1715472000000},"content-version":"am","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.vaccine.2023.03.058","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T08:17:12Z","timestamp":1681892232000},"page":"3266-3274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cross sectional survey of Varicella-Zoster virus and measles seropositivity in people living with HIV in a Parisian suburb and a review of current immunization guidelines"],"prefix":"10.1016","volume":"41","author":[{"given":"A.","family":"Kolakowska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9gol\u00e8ne","family":"Brichler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9loise","family":"Delagr\u00e8verie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Marin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed-Chakib","family":"Alloui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johann","family":"Cailhol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.03.058_b0005","doi-asserted-by":"crossref","first-page":"e0176845","DOI":"10.1371\/journal.pone.0176845","article-title":"The natural history of varicella zoster virus infection in Norway: Further insights on exogenous boosting and progressive immunity to herpes zoster","volume":"12","author":"Marangi","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.03.058_b0010","article-title":"Measles still spreads in Europe: who is responsible for the failure to vaccinate?","volume":"18(October (Suppl. 5)):50\u20136","author":"Carrillo-Santisteve","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2023.03.058_b0015","article-title":"Spotlight on measles 2010: update on the ongoing measles outbreak in France, 2008Y2010","volume":"15","author":"du Chatelet","year":"2010","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2023.03.058_b0020","doi-asserted-by":"crossref","unstructured":"Rasmussen, L. et al. Rasmussen LD, Fonager J, Knudsen LK, Andersen PH, R\u00f8nn J, Poulsen MW, Franck KT, Fischer TK. Phylogenetic and epidemiological analysis of measles outbreaks in Denmark, 2013 to 2014. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull 20, 27\u201336 (2015).","DOI":"10.2807\/1560-7917.ES.2015.20.39.30027"},{"key":"10.1016\/j.vaccine.2023.03.058_b0025","first-page":"12","article-title":"The state of measles and rubella in the WHO European Region, 2013","volume":"20","author":"Muscat","year":"2014","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2023.03.058_b0030","doi-asserted-by":"crossref","first-page":"e716","DOI":"10.1016\/j.ijid.2011.06.001","article-title":"Comparison of two strategies to prevent varicella outbreaks in housing facilities for asylum seekers","volume":"15","author":"de Valliere","year":"2011","journal-title":"Int J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2023.03.058_b0035","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1086\/527419","article-title":"Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004","volume":"197","author":"Lopez","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.03.058_b0040","first-page":"8","article-title":"Infectious disease surveillance of migrant populations in Calais et \u00e0 Grande-Synthe, France, November 2015- October 2016","volume":"19\u201320","author":"Chaud","year":"2017","journal-title":"BEH"},{"key":"10.1016\/j.vaccine.2023.03.058_b0045","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.46.17-00020","article-title":"An outbreak of chickenpox in an asylum seeker centre in Italy: outbreak investigation and validity of reported chickenpox history, December 2015\u2013May 2016","volume":"22","author":"Vairo","year":"2017","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.vaccine.2023.03.058_b0050","unstructured":"R\u00e9partition des immigr\u00e9es par groupe de pays de naissance en 2018, INSEE, 25 juin 2019."},{"key":"10.1016\/j.vaccine.2023.03.058_b0055","unstructured":"Population des r\u00e9gions au 1er janvier - Insee, Acc\u00e8s Internet le 09\/11\/2019: http:\/\/www.insee.fr\/fr\/themes\/tableau.asp?reg_id=99&ref_id=CMRSOS02137."},{"key":"10.1016\/j.vaccine.2023.03.058_b0060","unstructured":"Sant\u00e9 Publique France. Nouvelles donn\u00e9es de surveillance du VIH en France. Publi\u00e9 le 28 mars 2019."},{"key":"10.1016\/j.vaccine.2023.03.058_b0065","doi-asserted-by":"crossref","unstructured":"Candevi\u0307R, A. et al. Low immunity against vaccine preventable diseases in Turkish HIV cohort. Turk J Med Sci 51, 2311\u20132317 (2021).","DOI":"10.3906\/sag-2102-14"},{"key":"10.1016\/j.vaccine.2023.03.058_b0070","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40121-017-0166-x","article-title":"Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations. Part I","volume":"6","author":"Crum-Cianflone","year":"2017","journal-title":"Infectious Diseases and Therapy"},{"key":"10.1016\/j.vaccine.2023.03.058_b0075","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1017\/S095026881600217X","article-title":"Measles, mumps, rubella and VZV: importance of serological testing of vaccine-preventable diseases in young adults living with HIV in Germany","volume":"145","author":"Schwarze-Zander","year":"2017","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2023.03.058_b0080","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/QAD.0000000000000549","article-title":"High prevalence of measles seronega- tivity in adults with HIV infection born in the era of measles vaccination in northern France","volume":"29","author":"Lambert","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2023.03.058_b0085","doi-asserted-by":"crossref","unstructured":"Llenas-Garc\u0131\u0301a J, Rubio R, Hernando A, Arrazola P, Pulido F. Do HIV-positive adult immigrants need to be screened for measles\u2013mumps\u2013rubella and varicella zoster virus immunization? AIDS Care. 2013;25:980\u20139.","DOI":"10.1080\/09540121.2012.748881"},{"issue":"1","key":"10.1016\/j.vaccine.2023.03.058_b0090","doi-asserted-by":"crossref","first-page":"73_ 80","DOI":"10.1016\/j.jinf.2010.04.004","article-title":"Seroprevalence of common vaccine-preventable viral infections in HIV-positive adults","volume":"61","author":"Molton","year":"2010","journal-title":"J Infect"},{"issue":"45","key":"10.1016\/j.vaccine.2023.03.058_b0095","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.1016\/j.vaccine.2014.07.114","article-title":"High need forMMR vaccination in HIV infected adults in Austria","volume":"32","author":"Grabmeier-Pfistershammer","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2023.03.058_b0100","doi-asserted-by":"crossref","first-page":"20_24","DOI":"10.7326\/0003-4819-146-1-200701020-00005","article-title":"Susceptibility to measles, mumps, and rubella in newly arrived adult immigrants and refugees","volume":"146","author":"Greenaway","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2023.03.058_b0105","unstructured":"Institut de veille sanitaire, Lepoutre A, Antona D, Fonteneau L, Baudon C, Halftermeyer-Zhou F, et al. Enqu\u00eate nationale de s\u00e9ropr\u00e9valence des maladies infectieuses, S\u00e9roInf, 2009\u20132010, 1ers r\u00e9sultats. 12\u00e8mes JNI, Montpellier 8-10 juin 2011. Saint-Maurice: INVS; 2011. http:\/\/www.infectiologie.com\/site\/medias\/JNI\/JNI11\/CT\/JNI 2011-Sero-Inf-Lepoutre.pdf."},{"key":"10.1016\/j.vaccine.2023.03.058_b0110","first-page":"738","article-title":"Infection par le virus Varicella zoster chez l\u2019adulte : au-del\u00e0 du zona ?","volume":"2","author":"Buvelot","year":"2016","journal-title":"Rev Med Suisse"},{"key":"10.1016\/j.vaccine.2023.03.058_b0115","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-12-140","article-title":"Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population","volume":"12","author":"van Rijckevorsel","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2023.03.058_b0120","article-title":"Varicella zoster virus prevalence in Metro manila","volume":"S633\u20135","author":"Barzaga","year":"1994","journal-title":"Philippines J Am Med Assoc (SEA)"},{"key":"10.1016\/j.vaccine.2023.03.058_b0125","article-title":"Age related sroprevalence of antibodies to varicella in India","volume":"37","author":"Lokeshwar","year":"2000","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.vaccine.2023.03.058_b0130","first-page":"129","article-title":"Prevalence of antivaricella zoster IgG antibody in undergraduate students","volume":"14","author":"Bhattarakosol","year":"1996","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.vaccine.2023.03.058_b0135","article-title":"Seroprevalence of varicella zoster virus infections in Colombo District","volume":"61","author":"Liyanage","year":"2007","journal-title":"Sri Lanka Indian J Med Sci"},{"key":"10.1016\/j.vaccine.2023.03.058_b0140","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1046\/j.1365-3156.1998.00316.x","article-title":"Review of varicella zoster seroepidemiology in India and Southeast Asia","volume":"3","author":"Lee","year":"1998","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.vaccine.2023.03.058_b0145","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/archinte.1990.00390170032008","article-title":"Varicella outbreaks in Army recruits from Puerto Rico. Varicella susceptibility in a population from the tropics","volume":"150","author":"Longfield","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.vaccine.2023.03.058_b0150","first-page":"82","article-title":"Prevalencia de varicela en una poblacion de Buenos Aires y Cordoba","volume":"98","author":"Gentile","year":"2000","journal-title":"Arch Arg Pediat"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2023.03.058_b0155","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1086\/514262","article-title":"Adult susceptibility to varicella in the tropics is a rural phenomenon due to the lack of previous exposure","volume":"178","author":"Mandal","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.03.058_b0160","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4269\/ajtmh.2001.64.131","article-title":"Effect of climatic factors and population density on varicella zoster virus epidemiology within a tropical country","volume":"64","author":"Lolekha","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2023.03.058_b0165","doi-asserted-by":"crossref","unstructured":"R eis AD, Pannuti CS, de Souza VA. Prevalence of varicella-zoster virus antibodies in young adults from different Brazilian climatic regions. Rev Soc Bras Med Trop 2003;36:317-20.","DOI":"10.1590\/S0037-86822003000300001"},{"key":"10.1016\/j.vaccine.2023.03.058_b0170","doi-asserted-by":"crossref","unstructured":"Sauerbrei A. Differences in varicellazoster virus seroepidemiology between temperate and tropical regions. Indian J Med Sci 2007;61:123-4. 28 MacMahon E, Brown LJ, Bexley S, Snashall DC, Patel D. Identification of potential candidates for varicella vaccination by history\u00a0: Questionnaire and seroprevalence study. BMJ 2004;329:551-2.","DOI":"10.1136\/bmj.38170.691956.AE"},{"key":"10.1016\/j.vaccine.2023.03.058_b0175","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3109\/00365548.2010.511259","article-title":"Chickenpox in a Swiss prison : Susceptibility, post-exposure vaccination and control measures","volume":"42","author":"G\u00e9taz","year":"2010","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.03.058_b0180","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.jiph.2017.01.019","article-title":"Seroepidemiology of hepatitis A, hepatitis B and varicella virus in people living with HIV in Ireland","volume":"10","author":"Sadlier","year":"2017","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.vaccine.2023.03.058_b0185","unstructured":"Institut de Veille Sanitaire. Surveillance de la rougeole en France. Bilan et \u00e9volution en vue de l\u2019\u00e9limination de la maladie. 8 d\u00e9cembre 2003."},{"key":"10.1016\/j.vaccine.2023.03.058_b0190","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3390\/vaccines8010066","article-title":"Seroprevalence to Measles Virus after Vaccination or Natural Infection in an Adult Population, in Italy","volume":"8","author":"Anichini","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2023.03.058_b0195","doi-asserted-by":"crossref","unstructured":"Bianchi FP et al. Long-term immunogenicity after measles vaccine vs. wild infection: an Italian retrospective cohort study. Human Vaccines & Immunotherapeutics 17, 2078\u20132084 (2021).","DOI":"10.1080\/21645515.2020.1871296"},{"key":"10.1016\/j.vaccine.2023.03.058_b0200","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3390\/v8100282","article-title":"The Immune Response in Measles: Virus Control, Clearance and Protective Immunity","volume":"8","author":"Griffin","year":"2016","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.vaccine.2023.03.058_b0205","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/14760584.2020.1791091","article-title":"Prevalence and management of measles susceptibility in healthcare workers in Italy: a systematic review and meta-analysis","volume":"19","author":"Bianchi","year":"2020","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2023.03.058_b0210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0008-8749(75)80002-5","article-title":"Additional evidence that the cell-associated immune system is the primary host defense against measles (rubeola)","volume":"17","author":"Ruckdeschel","year":"1975","journal-title":"Cell Immunol"},{"key":"10.1016\/j.vaccine.2023.03.058_b0215","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1006\/bulm.1999.0126","article-title":"Modeling the Effects of Varicella Vaccination Programs on the Incidence of Chickenpox and Shingles","volume":"61","author":"Schuette","year":"1999","journal-title":"Bull Math Biol"},{"key":"10.1016\/j.vaccine.2023.03.058_b0220","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1017\/S0950268800004714","article-title":"Modelling the impact of immunization on the epidemiology of varicella zoster virus","volume":"125","author":"Brisson","year":"2000","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2023.03.058_b0225","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1017\/S0950268809990768","article-title":"Modelling the impact of varicella vaccination on varicella and zoster","volume":"138","author":"Karhunen","year":"2010","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2023.03.058_b0230","doi-asserted-by":"crossref","first-page":"e60732","DOI":"10.1371\/journal.pone.0060732","article-title":"Perspectives on the Impact of Varicella Immunization on Herpes Zoster. A Model-Based Evaluation from Three European Countries","volume":"8","author":"Poletti","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.03.058_b0235","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jcv.2016.12.001","article-title":"A systematic review and meta-analysis of seroprevalence of varicella zoster virus: A nationwide population-based study","volume":"87","author":"Amjadi","year":"2017","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2023.03.058_b0240","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/INF.0000000000001422","article-title":"Measles and Rubella Seroprevalence Among HIV\u2013infected and Uninfected Zambian Youth","volume":"36","author":"Sutcliffe","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2023.03.058_b0245","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1097\/00002030-199211000-00013","article-title":"Prevalence of measles antibodies in adults with HIV infection: possible risk factors of measles seronegativity","volume":"6","author":"Kemper","year":"1992","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2023.03.058_b0250","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12981-018-0212-0","article-title":"Association between quantitative varicella-zoster virus antibody levels and zoster reactivation in HIV-infected persons","volume":"15","author":"Pomerantz","year":"2018","journal-title":"AIDS Res Ther"},{"key":"10.1016\/j.vaccine.2023.03.058_b0255","doi-asserted-by":"crossref","DOI":"10.1001\/jama.1992.03480090085032","article-title":"Severe measles in immunocompromised patients","author":"Kaplan","year":"199226712371241","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2023.03.058_b0260","first-page":"3","volume":"19","author":"Bonhoeffer","year":"2008","journal-title":"Vaccination contre la varicelle en Suisse"},{"key":"10.1016\/j.vaccine.2023.03.058_b0265","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/archderm.1990.01670320057007","article-title":"Varicella in patients infected with the human immunodeficiency virus","volume":"126","author":"Perronne","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.vaccine.2023.03.058_b0270","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jcv.2014.02.008","article-title":"Fulminant VZV infection in an adult AIDS patient treated with steroids: a case report","volume":"60","author":"Grilli","year":"2014","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2023.03.058_b0275","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jcv.2013.10.027","article-title":"Disseminated vaccine-\u00ad-strain varicella as initial presentation of the acquired immunodeficiency syndrome: a case report and review of the literature","volume":"59","author":"Maves","year":"2014","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2023.03.058_b0280","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12879-020-4872-8","article-title":"Fulminant central nervous system varicella-zoster virus infection unexpectedly diagnosed by metagenomic next-generation sequencing in an HIV-infected patient: a case report","volume":"20","author":"Fang","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2023.03.058_b0285","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1186\/s12879-021-06611-9","article-title":"A case of paraplegia due to asymptomatic varicella-zoster virus infection in AIDS patient unexpectedly diagnosed by CSF metagenomic next-generation sequencing","volume":"21","author":"Xie","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2023.03.058_b0290","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/jmv.27629","article-title":"Immunogenicity and safety of the BNT162B2 COVID-19 mrna vaccine in PLWH: A monocentric study in Bari, Italy","volume":"94","author":"Milano","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2023.03.058_b0295","article-title":"Identification of potential candidates for varicella vaccination by history: questionnaire and seroprevalence study","volume":"329:551e2","author":"MacMahon","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2023.03.058_b0300","doi-asserted-by":"crossref","unstructured":"Alanen A, Kahala K, Vahlberg T, Koskela P, Vainionpaa R. Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland. BJOG 2005;112:50e6.","DOI":"10.1111\/j.1471-0528.2004.00320.x"},{"key":"10.1016\/j.vaccine.2023.03.058_b0305","doi-asserted-by":"crossref","unstructured":"C hristiansen D, Barnett ED. Comparison of varicella history with presence of varicella antibody in refugees. Vaccine 2004; 22:4233-7.","DOI":"10.1016\/j.vaccine.2004.04.024"},{"issue":"2","key":"10.1016\/j.vaccine.2023.03.058_b0310","doi-asserted-by":"crossref","first-page":"e315_ 322","DOI":"10.1542\/peds.2005-2616","article-title":"Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: Loss of specific antibodies against attenuated vaccine strains and natural viral infection","volume":"118","author":"Bekker","year":"2006","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.vaccine.2023.03.058_b0315","doi-asserted-by":"crossref","first-page":"499_503","DOI":"10.1016\/S1473-3099(10)70117-1","article-title":"Dysfunctional B-cell responses during HIV-1 infection: Implication for influenza vaccination and highly active antiretroviral therapy","volume":"10","author":"Cagigi","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"14","key":"10.1016\/j.vaccine.2023.03.058_b0320","doi-asserted-by":"crossref","first-page":"2015_2023","DOI":"10.1097\/00002030-200309260-00002","article-title":"Nadir CD4 T-cell count and numbers of CD28 CD4 T-cells predict functional responses to immunizations in chronic HIV-1 infection","volume":"17","author":"Lange","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2023.03.058_b0325","year":"2019","journal-title":"Version"},{"key":"10.1016\/j.vaccine.2023.03.058_b0330","unstructured":"Haut Conseil de la sant\u00e9 publique. Vaccination des personnes immunod\u00e9prim\u00e9es ou aspl\u00e9niques. Recommandations. 2\u00e8me \u00e9dition \u2013 D\u00e9cembre 2014."},{"key":"10.1016\/j.vaccine.2023.03.058_b0335","unstructured":"British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults, (2015) http:\/\/www.bhiva.org\/vaccination-guidelines.aspx."},{"key":"10.1016\/j.vaccine.2023.03.058_b0340","unstructured":"ACIP Vaccine Recommendation and Guidelines. https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/index.html. Accessed Nov 16, 2019."},{"key":"10.1016\/j.vaccine.2023.03.058_b0345","unstructured":"Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. https:\/\/aidsinfo.nih. gov\/contentfiles\/lvguidelines\/adult_OI.pdf. Accessed Nov 12, 2019."},{"key":"10.1016\/j.vaccine.2023.03.058_b0350","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1093\/cid\/cit684","article-title":"IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2023.03.058_b0355","unstructured":"Blanc A. et al. Groupe d\u2019experts pour la prise en charge du VIH. (2018)."},{"key":"10.1016\/j.vaccine.2023.03.058_b0360","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1093\/cid\/cit684","article-title":"2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2023.03.058_b0365","unstructured":"World Health Organization Europe. Edited by Irina Eramova, Srdan Matic and Monique Munz. HIV\/AIDS treatment and care: clinical protocols for the WHO European region. 2007. Acc\u00e8s Internet le 12\/11\/2019.http:\/\/www.euro. who.int\/__data\/assets\/pdf_file\/0004\/78106\/E90840. pdf."},{"key":"10.1016\/j.vaccine.2023.03.058_b0370","unstructured":"World Health Organization. Vaccine position papers. http:\/\/www.who.int\/immunization\/documents\/positionpapers\/en\/. Accessed Nov 12, 2019."},{"key":"10.1016\/j.vaccine.2023.03.058_b0375","unstructured":"United Nations, Department of Economic and Social Affairs. Population division in France, international migrant stock. (2019)."},{"key":"10.1016\/j.vaccine.2023.03.058_b0380","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1586\/erv.12.45","article-title":"Evaluating measles vaccines: can we assess cellular immunity?","volume":"11","author":"De Vries","year":"2012","journal-title":"Expert Rev Vaccines"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23003511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23003511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:27:44Z","timestamp":1759404464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23003511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":76,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0264410X23003511"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.03.058","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cross sectional survey of Varicella-Zoster virus and measles seropositivity in people living with HIV in a Parisian suburb and a review of current immunization guidelines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.03.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}